Viatris Inc - Company Profile
Powered by 
All the data and insights you need on Viatris Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Viatris Inc Strategy Report
- Understand Viatris Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Viatris Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Viatris Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Robert J. Coury
Chairman Executive BoardMr. Robert J. Coury has been the Chairman of the company since 2020. Prior to this role, he served as the Vice Chairman and as the Chief Executive Officer from September 2002 until January 2012 and as the Executive Chairman from 2012 at Mylan. Prior to Mylan, Mr. Coury was the principal of Coury Consulting, a boutique business advisory firm that he formed in 1989, and The Coury Financial Group, a financial and estate planning firm, which he founded in 1984. He is also the founder and President of the Robert J. Coury Family Foundation, a charitable organization. He also serves as the Director of the company.
Scott A. Smith
Director; Chief Executive Officer Executive BoardMr. Scott A. Smith has been the Chief Financial Officer of the company since April 2023. He also served as a Director of the company since December 2022. Prior to this, he served as a Chairman of Triumvira Immunologics. Previously he served at GreenRiver Biopharma, BioAtla and Spring Bank Pharmaceuticals, Celgene, Biovail and Pfizer.
Paul Campbell
Controller; Chief Accounting Officer Senior ManagementMr. Paul Campbell has been the Chief Accounting Officer and Corporate Controller since 2020. Prior to that, he served as the Chief Accounting Officer, Senior Vice President and Controller at Mylan. Previously he also served in various senior leadership roles at Mylan.
Corinne Le Goff
Chief Commercial Officer Senior ManagementMS. Corinne Le Goff has been the Chief Commercial Officer of the company Since April 2024. Prior to this she served as President and Chief Executive Officer of Imunon. Previously she served as Chief Commercial Officer at Moderna.
Anthony Mauro
President - North America Senior ManagementMr. Anthony Mauro has been the President of Developed Markets of the company since 2020. Prior to this, he served as the Chief Commercial Officer at Mylan since 2016. Prior to this role, he served as the President (North America) of Mylan. Before that, Mr. Mauro held various Senior Management positions including the President of Mylan Pharmaceuticals Inc; Vice President of North America Strategic Development; Chief Operating Officer of Mylan Pharmaceuticals ULC in Canada; and Vice President of North America Sales. Previously, he served as the Chairman for the US Generic Pharmaceutical Association (GPhA). Prior to that Mr. Mauro served two consecutive terms as Vice Chairman of the board for GPhA.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer